Genetic background affects induced pluripotent stem cell generation
The influence of genetic background on the ability to generate induced pluripotent stem cells (iPSCs) has the potential to impact future applications, but has yet to be examined in detail. The purpose of this study was to determine if genetic background affects the efficiency of generating iPSCs dur...
Gespeichert in:
Veröffentlicht in: | Stem cell research & therapy 2012-08, Vol.3 (4), p.30-30, Article 30 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 30 |
---|---|
container_issue | 4 |
container_start_page | 30 |
container_title | Stem cell research & therapy |
container_volume | 3 |
creator | Schnabel, Lauren V Abratte, Christian M Schimenti, John C Southard, Teresa L Fortier, Lisa A |
description | The influence of genetic background on the ability to generate induced pluripotent stem cells (iPSCs) has the potential to impact future applications, but has yet to be examined in detail. The purpose of this study was to determine if genetic background affects the efficiency of generating iPSCs during early reprograming as well as the pluripotent stability of the iPSCs during later stages of reprograming.
Mouse embryonic fibroblasts (MEFs) were isolated from six strains of mice (NON/LtJ; C57BL/6J; DBA/2J; BALB/cJ; 129S1/SvlmJ; CAST/EiJ) that were selected based on genetic diversity and differences in ability to produce embryonic stem cell (ESC) lines. MEFs were reprogramed via doxycycline-inducible lentiviral transduction of murine Oct4, Klf4, Sox2, and c-Myc. Differences in efficiency to generate iPSCs were assessed by comparing the total number of colonies, the percentage of colonies positive for alkaline phosphatase staining and the percentage of cells positive for SSEA1. iPSC colonies were expanded to establish doxycycline-independent cell lines whose pluripotency was then evaluated via ability to form teratomas in NOD.CB17-Prkdcscid/J mice. Proliferation of non-transduced parent MEFs from each strain was also examined over ten days under conditions that simulated reprograming.
NON/LtJ and CAST/EiJ strains were more efficient than other strains in generating iPSCs for all parameters measured and parent MEFs from these strains were more proliferative than those from other strains. Doxycycline-independent iPSC lines were established using standard conditions for all strains except BALB/cJ, which required a higher concentration (5x) of leukemia inhibitory factor (LIF). iPSCs from all strains were capable of producing teratomas in NOD.CB17-Prkdcscid/J mice.
The results of this study suggest that genetic background does affect iPSC generation and pluripotent stability. In addition, our results demonstrate that strain differences in efficiency to generate iPSCs during the early stages of reprograming are correlated with those observed in proliferation of parent MEFs. These findings have important implications both for future iPSC applications as well as for future investigation into determining the genes responsible for reprograming efficiency and stability. |
doi_str_mv | 10.1186/scrt121 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3580468</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534486464</galeid><sourcerecordid>A534486464</sourcerecordid><originalsourceid>FETCH-LOGICAL-c501t-666841a60e673c16442784ae4a125267a814f0eb6883d4a0aaad502db63e3d9b3</originalsourceid><addsrcrecordid>eNptkV1LHDEUhoNYqljpP5CBgtKLtfmaTLwpyNJaQSj04zqcSc7MRmcmS5IR--8bWSs70OQi4eR5X3LOS8h7Ri8Z0-pTsjEzzg7IMWvqZqVqxg_37kfkNKV7WpYQlCr5lhxxrhW_EvKYrG9wwuxt1YJ96GOYJ1dB16HNqfKTmy26ajvM0W9DxilXKeNYWRyGqi_CCNmH6R1508GQ8PTlPCG_v375tf62uvt-c7u-vlvZmrK8UkppyUBRVI2wTEnJGy0BJTBec9WAZrKj2CqthZNAAcDVlLtWCRTuqhUn5PPOdzu3Izpb_hNhMNvoR4h_TABvli-T35g-PBpRayqVLgYfdgY9DGj81IWC2dEna65rIaVWUslCXf6HKtvh6G2YsPOlvhB8XAgKk_Ep9zCnZG5__liy53vsBmHImxSG-XmOaQle7EAbQ0oRu9c-GTXPsZuX2At5tj-WV-5fyOIv2cemKA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Genetic background affects induced pluripotent stem cell generation</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><source>Springer Nature OA/Free Journals</source><creator>Schnabel, Lauren V ; Abratte, Christian M ; Schimenti, John C ; Southard, Teresa L ; Fortier, Lisa A</creator><creatorcontrib>Schnabel, Lauren V ; Abratte, Christian M ; Schimenti, John C ; Southard, Teresa L ; Fortier, Lisa A</creatorcontrib><description>The influence of genetic background on the ability to generate induced pluripotent stem cells (iPSCs) has the potential to impact future applications, but has yet to be examined in detail. The purpose of this study was to determine if genetic background affects the efficiency of generating iPSCs during early reprograming as well as the pluripotent stability of the iPSCs during later stages of reprograming.
Mouse embryonic fibroblasts (MEFs) were isolated from six strains of mice (NON/LtJ; C57BL/6J; DBA/2J; BALB/cJ; 129S1/SvlmJ; CAST/EiJ) that were selected based on genetic diversity and differences in ability to produce embryonic stem cell (ESC) lines. MEFs were reprogramed via doxycycline-inducible lentiviral transduction of murine Oct4, Klf4, Sox2, and c-Myc. Differences in efficiency to generate iPSCs were assessed by comparing the total number of colonies, the percentage of colonies positive for alkaline phosphatase staining and the percentage of cells positive for SSEA1. iPSC colonies were expanded to establish doxycycline-independent cell lines whose pluripotency was then evaluated via ability to form teratomas in NOD.CB17-Prkdcscid/J mice. Proliferation of non-transduced parent MEFs from each strain was also examined over ten days under conditions that simulated reprograming.
NON/LtJ and CAST/EiJ strains were more efficient than other strains in generating iPSCs for all parameters measured and parent MEFs from these strains were more proliferative than those from other strains. Doxycycline-independent iPSC lines were established using standard conditions for all strains except BALB/cJ, which required a higher concentration (5x) of leukemia inhibitory factor (LIF). iPSCs from all strains were capable of producing teratomas in NOD.CB17-Prkdcscid/J mice.
The results of this study suggest that genetic background does affect iPSC generation and pluripotent stability. In addition, our results demonstrate that strain differences in efficiency to generate iPSCs during the early stages of reprograming are correlated with those observed in proliferation of parent MEFs. These findings have important implications both for future iPSC applications as well as for future investigation into determining the genes responsible for reprograming efficiency and stability.</description><identifier>ISSN: 1757-6512</identifier><identifier>EISSN: 1757-6512</identifier><identifier>DOI: 10.1186/scrt121</identifier><identifier>PMID: 22862934</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Animals ; Biological diversity ; Cell Differentiation ; Cell Proliferation ; Cells, Cultured ; Cellular Reprogramming ; Cytogenetics ; Embryo, Mammalian - cytology ; Embryonic stem cells ; Fibroblasts - cytology ; Fibroblasts - metabolism ; Genetic aspects ; Genetic research ; Induced Pluripotent Stem Cells - cytology ; Induced Pluripotent Stem Cells - transplantation ; Leukemia ; Mice ; Mice, Inbred BALB C ; Mice, Inbred C57BL ; Mice, Inbred DBA ; Mice, Inbred NOD ; Mice, SCID ; Phosphatases ; Physiological aspects ; Stem cells ; Teratoma - pathology</subject><ispartof>Stem cell research & therapy, 2012-08, Vol.3 (4), p.30-30, Article 30</ispartof><rights>COPYRIGHT 2012 BioMed Central Ltd.</rights><rights>Copyright ©2012 Schnabel et al.; licensee BioMed Central Ltd. 2012 Schnabel et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c501t-666841a60e673c16442784ae4a125267a814f0eb6883d4a0aaad502db63e3d9b3</citedby><cites>FETCH-LOGICAL-c501t-666841a60e673c16442784ae4a125267a814f0eb6883d4a0aaad502db63e3d9b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580468/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580468/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22862934$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schnabel, Lauren V</creatorcontrib><creatorcontrib>Abratte, Christian M</creatorcontrib><creatorcontrib>Schimenti, John C</creatorcontrib><creatorcontrib>Southard, Teresa L</creatorcontrib><creatorcontrib>Fortier, Lisa A</creatorcontrib><title>Genetic background affects induced pluripotent stem cell generation</title><title>Stem cell research & therapy</title><addtitle>Stem Cell Res Ther</addtitle><description>The influence of genetic background on the ability to generate induced pluripotent stem cells (iPSCs) has the potential to impact future applications, but has yet to be examined in detail. The purpose of this study was to determine if genetic background affects the efficiency of generating iPSCs during early reprograming as well as the pluripotent stability of the iPSCs during later stages of reprograming.
Mouse embryonic fibroblasts (MEFs) were isolated from six strains of mice (NON/LtJ; C57BL/6J; DBA/2J; BALB/cJ; 129S1/SvlmJ; CAST/EiJ) that were selected based on genetic diversity and differences in ability to produce embryonic stem cell (ESC) lines. MEFs were reprogramed via doxycycline-inducible lentiviral transduction of murine Oct4, Klf4, Sox2, and c-Myc. Differences in efficiency to generate iPSCs were assessed by comparing the total number of colonies, the percentage of colonies positive for alkaline phosphatase staining and the percentage of cells positive for SSEA1. iPSC colonies were expanded to establish doxycycline-independent cell lines whose pluripotency was then evaluated via ability to form teratomas in NOD.CB17-Prkdcscid/J mice. Proliferation of non-transduced parent MEFs from each strain was also examined over ten days under conditions that simulated reprograming.
NON/LtJ and CAST/EiJ strains were more efficient than other strains in generating iPSCs for all parameters measured and parent MEFs from these strains were more proliferative than those from other strains. Doxycycline-independent iPSC lines were established using standard conditions for all strains except BALB/cJ, which required a higher concentration (5x) of leukemia inhibitory factor (LIF). iPSCs from all strains were capable of producing teratomas in NOD.CB17-Prkdcscid/J mice.
The results of this study suggest that genetic background does affect iPSC generation and pluripotent stability. In addition, our results demonstrate that strain differences in efficiency to generate iPSCs during the early stages of reprograming are correlated with those observed in proliferation of parent MEFs. These findings have important implications both for future iPSC applications as well as for future investigation into determining the genes responsible for reprograming efficiency and stability.</description><subject>Animals</subject><subject>Biological diversity</subject><subject>Cell Differentiation</subject><subject>Cell Proliferation</subject><subject>Cells, Cultured</subject><subject>Cellular Reprogramming</subject><subject>Cytogenetics</subject><subject>Embryo, Mammalian - cytology</subject><subject>Embryonic stem cells</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - metabolism</subject><subject>Genetic aspects</subject><subject>Genetic research</subject><subject>Induced Pluripotent Stem Cells - cytology</subject><subject>Induced Pluripotent Stem Cells - transplantation</subject><subject>Leukemia</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Inbred DBA</subject><subject>Mice, Inbred NOD</subject><subject>Mice, SCID</subject><subject>Phosphatases</subject><subject>Physiological aspects</subject><subject>Stem cells</subject><subject>Teratoma - pathology</subject><issn>1757-6512</issn><issn>1757-6512</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkV1LHDEUhoNYqljpP5CBgtKLtfmaTLwpyNJaQSj04zqcSc7MRmcmS5IR--8bWSs70OQi4eR5X3LOS8h7Ri8Z0-pTsjEzzg7IMWvqZqVqxg_37kfkNKV7WpYQlCr5lhxxrhW_EvKYrG9wwuxt1YJ96GOYJ1dB16HNqfKTmy26ajvM0W9DxilXKeNYWRyGqi_CCNmH6R1508GQ8PTlPCG_v375tf62uvt-c7u-vlvZmrK8UkppyUBRVI2wTEnJGy0BJTBec9WAZrKj2CqthZNAAcDVlLtWCRTuqhUn5PPOdzu3Izpb_hNhMNvoR4h_TABvli-T35g-PBpRayqVLgYfdgY9DGj81IWC2dEna65rIaVWUslCXf6HKtvh6G2YsPOlvhB8XAgKk_Ep9zCnZG5__liy53vsBmHImxSG-XmOaQle7EAbQ0oRu9c-GTXPsZuX2At5tj-WV-5fyOIv2cemKA</recordid><startdate>20120803</startdate><enddate>20120803</enddate><creator>Schnabel, Lauren V</creator><creator>Abratte, Christian M</creator><creator>Schimenti, John C</creator><creator>Southard, Teresa L</creator><creator>Fortier, Lisa A</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>5PM</scope></search><sort><creationdate>20120803</creationdate><title>Genetic background affects induced pluripotent stem cell generation</title><author>Schnabel, Lauren V ; Abratte, Christian M ; Schimenti, John C ; Southard, Teresa L ; Fortier, Lisa A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c501t-666841a60e673c16442784ae4a125267a814f0eb6883d4a0aaad502db63e3d9b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Animals</topic><topic>Biological diversity</topic><topic>Cell Differentiation</topic><topic>Cell Proliferation</topic><topic>Cells, Cultured</topic><topic>Cellular Reprogramming</topic><topic>Cytogenetics</topic><topic>Embryo, Mammalian - cytology</topic><topic>Embryonic stem cells</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - metabolism</topic><topic>Genetic aspects</topic><topic>Genetic research</topic><topic>Induced Pluripotent Stem Cells - cytology</topic><topic>Induced Pluripotent Stem Cells - transplantation</topic><topic>Leukemia</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Inbred DBA</topic><topic>Mice, Inbred NOD</topic><topic>Mice, SCID</topic><topic>Phosphatases</topic><topic>Physiological aspects</topic><topic>Stem cells</topic><topic>Teratoma - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schnabel, Lauren V</creatorcontrib><creatorcontrib>Abratte, Christian M</creatorcontrib><creatorcontrib>Schimenti, John C</creatorcontrib><creatorcontrib>Southard, Teresa L</creatorcontrib><creatorcontrib>Fortier, Lisa A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Stem cell research & therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schnabel, Lauren V</au><au>Abratte, Christian M</au><au>Schimenti, John C</au><au>Southard, Teresa L</au><au>Fortier, Lisa A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Genetic background affects induced pluripotent stem cell generation</atitle><jtitle>Stem cell research & therapy</jtitle><addtitle>Stem Cell Res Ther</addtitle><date>2012-08-03</date><risdate>2012</risdate><volume>3</volume><issue>4</issue><spage>30</spage><epage>30</epage><pages>30-30</pages><artnum>30</artnum><issn>1757-6512</issn><eissn>1757-6512</eissn><abstract>The influence of genetic background on the ability to generate induced pluripotent stem cells (iPSCs) has the potential to impact future applications, but has yet to be examined in detail. The purpose of this study was to determine if genetic background affects the efficiency of generating iPSCs during early reprograming as well as the pluripotent stability of the iPSCs during later stages of reprograming.
Mouse embryonic fibroblasts (MEFs) were isolated from six strains of mice (NON/LtJ; C57BL/6J; DBA/2J; BALB/cJ; 129S1/SvlmJ; CAST/EiJ) that were selected based on genetic diversity and differences in ability to produce embryonic stem cell (ESC) lines. MEFs were reprogramed via doxycycline-inducible lentiviral transduction of murine Oct4, Klf4, Sox2, and c-Myc. Differences in efficiency to generate iPSCs were assessed by comparing the total number of colonies, the percentage of colonies positive for alkaline phosphatase staining and the percentage of cells positive for SSEA1. iPSC colonies were expanded to establish doxycycline-independent cell lines whose pluripotency was then evaluated via ability to form teratomas in NOD.CB17-Prkdcscid/J mice. Proliferation of non-transduced parent MEFs from each strain was also examined over ten days under conditions that simulated reprograming.
NON/LtJ and CAST/EiJ strains were more efficient than other strains in generating iPSCs for all parameters measured and parent MEFs from these strains were more proliferative than those from other strains. Doxycycline-independent iPSC lines were established using standard conditions for all strains except BALB/cJ, which required a higher concentration (5x) of leukemia inhibitory factor (LIF). iPSCs from all strains were capable of producing teratomas in NOD.CB17-Prkdcscid/J mice.
The results of this study suggest that genetic background does affect iPSC generation and pluripotent stability. In addition, our results demonstrate that strain differences in efficiency to generate iPSCs during the early stages of reprograming are correlated with those observed in proliferation of parent MEFs. These findings have important implications both for future iPSC applications as well as for future investigation into determining the genes responsible for reprograming efficiency and stability.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>22862934</pmid><doi>10.1186/scrt121</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1757-6512 |
ispartof | Stem cell research & therapy, 2012-08, Vol.3 (4), p.30-30, Article 30 |
issn | 1757-6512 1757-6512 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3580468 |
source | MEDLINE; Springer Online Journals Complete; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central; Springer Nature OA/Free Journals |
subjects | Animals Biological diversity Cell Differentiation Cell Proliferation Cells, Cultured Cellular Reprogramming Cytogenetics Embryo, Mammalian - cytology Embryonic stem cells Fibroblasts - cytology Fibroblasts - metabolism Genetic aspects Genetic research Induced Pluripotent Stem Cells - cytology Induced Pluripotent Stem Cells - transplantation Leukemia Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Inbred DBA Mice, Inbred NOD Mice, SCID Phosphatases Physiological aspects Stem cells Teratoma - pathology |
title | Genetic background affects induced pluripotent stem cell generation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T03%3A31%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Genetic%20background%20affects%20induced%20pluripotent%20stem%20cell%20generation&rft.jtitle=Stem%20cell%20research%20&%20therapy&rft.au=Schnabel,%20Lauren%20V&rft.date=2012-08-03&rft.volume=3&rft.issue=4&rft.spage=30&rft.epage=30&rft.pages=30-30&rft.artnum=30&rft.issn=1757-6512&rft.eissn=1757-6512&rft_id=info:doi/10.1186/scrt121&rft_dat=%3Cgale_pubme%3EA534486464%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/22862934&rft_galeid=A534486464&rfr_iscdi=true |